Use of circulating tumor DNA (ctDNA) for early assessment of treatment response in patients with non-small cell lung cancer (NSCLC): A real-world (RW) analysis incorporating baseline ctDNA level and molecular response

被引：0
|
作者：
Gordon, Sean
Losic, Bojan
Quinn, Katie
Chang, Kyle
Liao, Jiemin
Chuang, Han-Yu
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5573
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5573
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [41] Classification Methods for Germline and Somatic Single Nucleotide Variant (SNV) in Circulating Tumor DNA (ctDNA) of Small Cell (SCLC) and Non-small Cell Lung Cancer (NSCLC)
    Woestmann, C.
    Ju, C.
    Jiang, J.
    Hinzmann, B.
    Herth, F.
    Kriegsmann, M.
    Heussel, C.
    Meister, M.
    Muley, T.
    Schneider, M.
    Thomas, M.
    Yaung, S.
    Wehnl, B.
    Palma, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (11): : S52 - S52
  • [42] Concordance between treatment-naive tissue and circulating tumour DNA (ctDNA) in late stage non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)
    Woestmann, C.
    Jiang, J.
    Palma, J. F.
    Ju, C.
    Heussel, C. P.
    Kriegsmann, M.
    Yaung, S.
    Thomas, M.
    Meister, M.
    Schneider, M.
    Herth, F.
    Muley, T.
    Wehnl, B.
    Hinzmann, B.
    ANNALS OF ONCOLOGY, 2020, 31 : S1041 - S1042
  • [43] Potential utility of methylation levels detected from circulating tumor DNA (ctDNA) in predicting molecular residual disease (MRD) in patients with resected non-small cell lung cancer (NSCLC).
    Hu, Hong
    Li, Hang
    Ma, Zelin
    Xiang, Jiaqing
    Zhang, Yawei
    Lizaso, Analyn
    Hou, Ting
    Guan, Xiaoqian
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [44] Circulating tumor DNA (ctDNA) for genomic profiling of non-small cell lung cancer (NSCLC): Experience in a large community-based cancer center.
    Suero-Abreu, Giselle Alexandra
    Velez, Miguel Gonzalez
    Proverbs-Singh, Tracy Ann
    Gutierrez, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] Residual of circulating tumor DNA (ctDNA) indicated therapeutic efficacy of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC).
    Wang, Zhehai
    Han, Xiao
    Guo, Jun
    Jia, Ming
    Zhu, Changbin
    Zhu, Dongyuan
    Zhang, Xiqin
    Tang, Xiaoyong
    Meng, Xiangjiao
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] Plasma circulating tumor DNA analysis (ctDNA) for molecular alteration detection in advanced non-small cell lung cancer (NSCLC) patients (pts) with isolated central nervous system (CNS) metastases (mts)
    Aldea, M.
    Hendriks, L.
    Mezquita, L.
    Remon-Masip, J.
    Planchard, D.
    Jovelet, C.
    Benitez, J. C.
    Gazzah, A.
    Naltet, C.
    Lavaud, P.
    Lacroix, L.
    Howarth, K.
    Morris, C.
    Green, E.
    Nicotra, C.
    Besse, B.
    ANNALS OF ONCOLOGY, 2019, 30 : 43 - 43
  • [47] Cell-Free Tumor DNA (ctDNA) Utility in Detection and Monitoring EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)
    Agulnik, J.
    Kasymjanova, G.
    Papadakis, A.
    Small, D.
    Sakr, L.
    Pepe, C.
    Wang, H.
    Cohen, V.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1035 - S1035
  • [48] REAL-WORLD UTILIZATION OF BRIGATINIB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)
    Lin, H. M.
    Pan, X.
    Hou, P.
    Huang, H.
    Baumann, P.
    Jahanzeb, M.
    VALUE IN HEALTH, 2019, 22 : S115 - S115
  • [49] Cell-free circulating tumour DNA (ctDNA) in the management of patients (pts) with non-biopsiable (Bx) advanced non-small cell lung cancer (NSCLC).
    Kushnir, MArina
    Murias, Carmen
    Winter, Helen
    Bain, Param
    Abbosh, Christopher
    Papadatos, Dionysis
    Newsom-Davis, Thomas
    Ahmad, Tanya
    Swanton, Charles
    Forster, Martin David
    Moore, David Allan
    Bennett, Philip
    Faull, Iris
    Lanman, Richard B.
    Arkenau, Hendrik-Tobias
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] The genomic landscape of non-small cell lung cancer (NSCLC) in East Asia using circulating tumour DNA (ctDNA) in clinical practice
    Cho, B. C.
    Loong, H. H. F.
    Tsai, C-M.
    Teo, M. L. P.
    Park, K.
    Kim, H. R.
    Lee, M.
    Olsen, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1362 - S1362
12345